Biological E gets nod for human trials of Covid-19 vaccine
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
India’s drug regulator has allowed Hyderabad-based Biological E to start phase-1 and 2 human trials in India for a vaccine against Covid-19.

The subject expert committee that advises the Drug Controller General of India on applications seeking permissions for new drugs, clinical trials and vaccines for Covid-19 gave its approval on October 26.

“The firm presented its revised protocol to conduct phase-1/2 clinical trials of the SARS-CoV-2 vaccine along with non-clinical toxicity data before the committee. After detailed deliberations, the committee recommended grant of permission to conduct the clinical trials,” the minutes of the meeting showed.

This will be the fourth vaccine to undergo clinical trials in India. The final phase of trials of the Oxford-AstraZeneca vaccine called Covishield and Bharat Biotech’s Covaxin will start soon while Zydus’s candidate is undergoing phase-2 trials.

The Serum Institute of India is conducting the trials for Covishield. Health minister Harsh Vardhan said a few days ago that the government hopes to administer Covid-19 vaccines to 250 million people in the country by July next year.

Source: https://health.economictimes.indiatimes.com/news/pharma/biological-e-gets-nod-for-human-trials-of-covid-19-vaccine/78922437
Like
Comment
Share